https://de.marketscreener.com/kurs/aktie/HORIZON-THERAPEUTICS-PUBL-18100076/news/Horizon-Therapeutics-plc-kundigt-neue-Informationen-zu-Inebilizumab-das-zur-Behandlung-des-Devic-36594255/?utm_source=telegram&utm_medium=social&utm_campaign=share